| Mr Homero Paniagua, APN | |
|
1001 Pleasant Valley Way, West Orange, NJ 07052 | |
| (973) 669-8448 | |
| (973) 669-9536 |
| Full Name | Mr Homero Paniagua |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 1001 Pleasant Valley Way, West Orange, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053700633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 26NJ00548000 (New Jersey) | Primary |
| Entity Name | Saint Barnabas Multi Specialty |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780632992 PECOS PAC ID: 3072500727 Enrollment ID: O20040427000024 |
News Archive
The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).
Continued improvements in the infant and maternal mortality rates will depend on interventions before a woman becomes pregnant, according to officials from the March of Dimes, the U.S. Centers for Disease Control and Prevention and other experts.
Research shows that pathologic prostate-specific antigen mass ratio is a significant predictor for biochemical recurrence-free survival following radical prostatectomy for localized prostate cancer in patients with negative surgical resection margins.
Wearable exoskeletons are coming to stay. Technological advancements in embedded computation and wearable mechatronics are enabling the production of new wearable exoskeletons that were not feasible a decade ago
Local health department directors across North Carolina are confused about state laws covering whether their facilities can be made smoke-free, but still strongly support such policies, according to a new University of North Carolina at Chapel Hill study.
› Verified 7 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).
Continued improvements in the infant and maternal mortality rates will depend on interventions before a woman becomes pregnant, according to officials from the March of Dimes, the U.S. Centers for Disease Control and Prevention and other experts.
Research shows that pathologic prostate-specific antigen mass ratio is a significant predictor for biochemical recurrence-free survival following radical prostatectomy for localized prostate cancer in patients with negative surgical resection margins.
Wearable exoskeletons are coming to stay. Technological advancements in embedded computation and wearable mechatronics are enabling the production of new wearable exoskeletons that were not feasible a decade ago
Local health department directors across North Carolina are confused about state laws covering whether their facilities can be made smoke-free, but still strongly support such policies, according to a new University of North Carolina at Chapel Hill study.
› Verified 7 days ago
| Entity Name | Sbmc Provider Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942748983 PECOS PAC ID: 8729344569 Enrollment ID: O20171109003416 |
News Archive
The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).
Continued improvements in the infant and maternal mortality rates will depend on interventions before a woman becomes pregnant, according to officials from the March of Dimes, the U.S. Centers for Disease Control and Prevention and other experts.
Research shows that pathologic prostate-specific antigen mass ratio is a significant predictor for biochemical recurrence-free survival following radical prostatectomy for localized prostate cancer in patients with negative surgical resection margins.
Wearable exoskeletons are coming to stay. Technological advancements in embedded computation and wearable mechatronics are enabling the production of new wearable exoskeletons that were not feasible a decade ago
Local health department directors across North Carolina are confused about state laws covering whether their facilities can be made smoke-free, but still strongly support such policies, according to a new University of North Carolina at Chapel Hill study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Homero Paniagua, APN 375 Mount Pleasant Avenue, Suite 250, West Orange, NJ 07052 Ph: (973) 323-1320 | Mr Homero Paniagua, APN 1001 Pleasant Valley Way, West Orange, NJ 07052 Ph: (973) 669-8448 |
News Archive
The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).
Continued improvements in the infant and maternal mortality rates will depend on interventions before a woman becomes pregnant, according to officials from the March of Dimes, the U.S. Centers for Disease Control and Prevention and other experts.
Research shows that pathologic prostate-specific antigen mass ratio is a significant predictor for biochemical recurrence-free survival following radical prostatectomy for localized prostate cancer in patients with negative surgical resection margins.
Wearable exoskeletons are coming to stay. Technological advancements in embedded computation and wearable mechatronics are enabling the production of new wearable exoskeletons that were not feasible a decade ago
Local health department directors across North Carolina are confused about state laws covering whether their facilities can be made smoke-free, but still strongly support such policies, according to a new University of North Carolina at Chapel Hill study.
› Verified 7 days ago
Yesica Cano, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 375 Mount Pleasant Ave, West Orange, NJ 07052 Phone: 973-731-9442 | |
Dr. Claude H. Rene-cunningham, DNP, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 105 Main St Apt 1a, West Orange, NJ 07052 Phone: 973-344-0300 | |
Rose Antony, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5 Brook End Dr, West Orange, NJ 07052 Phone: 973-324-3000 | |
Patricia Ann Shorrock, RN,APN,C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 Old Short Hills Rd, Suite 211, West Orange, NJ 07052 Phone: 973-736-4430 Fax: 973-736-3733 | |
Corine Iwuala, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 97 Mayfair Dr, West Orange, NJ 07052 Phone: 973-866-5350 Fax: 973-381-1634 | |
Michele Colon, APN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 347 Mount Pleasant Ave, Suite 205, West Orange, NJ 07052 Phone: 973-571-2121 |